Josh Enomoto

Josh Enomoto

As a financial analyst who has engaged in multimillion dollar projects with Global 500 companies, Joshua Enomoto provides an acute perspective of the investment markets.

A graduate of the University of California, San Diego, his professional experience covers multiple industries, including healthcare, civil engineering, and consumer electronics. Past contributions include leading the resolution of a critical liabilities dispute between two major electronics companies, and being awarded a speaking engagement in Tokyo, Japan, regarding supply chain efficiency protocols.

Currently based in San Diego, Josh is also an avid music composer and audio engineer, and spends his free time with multimedia pursuits.

Recent Articles

It’s Not Just the Allegations That Hurt Clover Health

Clover Health is under fire from short seller Hindenburg Research, sending CLOV stock careening toward the ground. But that’s not the only factor to consider regarding the embattled organization.

9 ETFs That Will Blossom as Reopening Accelerates

With an effort to reopen the economy underway, some individual companies will soar. But figuring out which one can be difficult, which augments the case for sector-specific ETFs.

Stellar Lumens’ Tech Impresses But Needs a North Star

While there’s no denying that the Stellar Lumens blockchain is innovative and practical, that doesn’t make the underlying XLM token a buy.

Why the Texas Cold Snap Is a Big Concern for Switchback Energy

On paper, SBE stock has an excellent narrative because of its important to EV infrastructure. But the Texas storm may have ruined this picture-perfect storyline.

7 Media Stocks Behind Big Upcoming 2021 Releases

Due to the lockdowns associated with the pandemic, media stocks took a hit in 2020. But they’re on the comeback trail this year.